Congress file hr3491-119, before Congress. Still to be decided as of 2026-07-20.
Latest action: Motion to reconsider laid on the table Agreed to without objection.
More Down syndrome research and clinical trials ahead NIH must now run a coordinated program studying Down syndrome across a person's lifetime, including new drug trials and ways to improve daily living for people with the condition.
Better care for linked health problems in Down syndrome The program targets research on conditions that often occur together with Down syndrome, like Alzheimer's disease and autoimmune disorders, which could lead to earlier diagnosis and better treatment options.
This bill provides statutory authority for a program of the National Institutes of Health (NIH) that carries out research and training relating to Down syndrome, including with respect to co-occurring conditions and improving the quality of life of affected individuals. The NIH must implement the program in consultation with relevant stakeholders and avoid duplicating existing NIH Down syndrome research.Biennially, the NIH must submit to Congress a report cataloging the research, including results that may be used in medical care or clinical research.
Read the official record for hr3491-119
See everything up for a vote · This week in Congress · See what we have filed with the clerk